# Universal Biotech

Shanghai-based, supplying life-science reagents, equipment, consumables and integrated technical services to higher-education institutions, research institutes, hospitals and biopharmaceutical companies, and acting as an authorised East China distributor for lines including BD Pharmingen.


Source: https://en.bioecon.ru/companies/universal-biotech/
Updated: 2026-08-18

- Country: China

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | CNY 1.08 billion (2025) | http://static.cninfo.com.cn/finalpage/2026-04-28/1225205422.PDF, https://money.finance.sina.com.cn/corp/view/vCB_AllBulletinDetail.php?id=12220147&stockid=301166 |
| Headcount | 698 employees | https://quote.cfi.cn/gsda/109432/301166.html |
| Production site | Nanjing R&D and production operation base (includes GMP-level production workshop) | http://static.cninfo.com.cn/finalpage/2026-04-28/1225205422.PDF, https://money.finance.sina.com.cn/corp/view/vCB_AllBulletinDetail.php?id=12220147&stockid=301166 |
| Capacity | The completion of the Nanjing R&D and production base is expected to significantly increase the production capacity for self-developed products such as recombinant proteins and IVD antibodies. | http://static.cninfo.com.cn/finalpage/2026-04-28/1225205422.PDF, https://money.finance.sina.com.cn/corp/view/vCB_AllBulletinDetail.php?id=12220147&stockid=301166 |
| Certification | AEO advanced certification, network security level 3 certification | http://static.cninfo.com.cn/finalpage/2026-04-28/1225205422.PDF |
| Regulatory approval | Operates under various licenses including Third-class medical device operation, Second-class value-added telecommunications business, and Hazardous chemical operation. [medium confidence] | https://quote.cfi.cn/gsda/109432/301166.html |
| Funding | Shanghai municipal government provides various subsidies, including up to RMB 30 million for eligible R&D projects and a 50 percent subsidy on low-interest loans for technological transformation or production expansion. [medium confidence] | https://itif.org/publications/2026/06/29/chinas-burgeoning-biopharmaceutical-competitiveness-demands-us-response/ |

Independent sources: itif.org, money.finance.sina.com.cn, quote.cfi.cn, static.cninfo.com.cn

## Technologies

- [Lab-equipment management & procurement](https://en.bioecon.ru/technology/lab-equipment-management-procurement/)